Edaravone Dexborneol Treatment Attenuates Neuronal Apoptosis and Improves Neurological Function by Suppressing 4-HNE-Associated Oxidative Stress After Subarachnoid Hemorrhage

Edaravone dexborneol is a novel neuroprotective drug that comprises edaravone and (+)-borneol in a 4:1 ratio. Phase II and III studies have demonstrated that Chinese patients treated with edaravone dexborneol within 48 h of AIS onset have better functional outcomes than those treated with edaravone...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Qian, Cai, Yichen, Zhu, Xiaoyu, Wang, Jing, Gao, Feng, Yang, Mingfeng, Mao, Leilei, Zhang, Zongyong, Sun, Baoliang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9068884/
https://www.ncbi.nlm.nih.gov/pubmed/35529450
http://dx.doi.org/10.3389/fphar.2022.848529

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9068884/
https://www.ncbi.nlm.nih.gov/pubmed/35529450
http://dx.doi.org/10.3389/fphar.2022.848529

Ejemplares similares